Spark Coverage Cup
Coverage Cup 20/05/2020
Firmly ensconced now in our third month of lockdown (check out Becca’s blog on our new routines), the Spark team has been reading, quizzing and zooming like old hands. We’ve also been thinking about cocktails and taking lots of pictures of cats, which is not news to anyone. However, speaking of news, it’s time for this week’s Coverage Cup round-up.
The winner was an excellent piece of feature coverage for the MuleSoft team on IDG Connect. The feature was based around MuleSoft’s recent survey of global IT decision makers and is an in-depth write-up around APIs. It looks at what IT teams are increasingly being asked to take on, which is particularly relevant given how much we’ve all relied on business technology in recent months.
There’s been some notable national coverage as well – firstly in The Times/Raconteur from the Dynatrace team, with comments on that perennial issue, cloud waste, quoted in a feature as part of the Cloud for Business supplement. Secondly, the Karhoo team scored an interview for the two co-CEOs in The Sunday Express, to talk about the future of mobility.
The Venafi team had a week of making the headlines with some company news around a recent acquisition, with coverage in all the big targets – including TechCrunch, Computer Weekly, and MicroScope – among several others. Much of the coverage looked at the positive fact that business deals are still going ahead, and enterprises continue to look to the future, despite the current upheaval.
On a science front, the Elsevier team has been busy with thought-leadership – scoring a couple of great byline placements in a US publication, R&D World. This included an article on ‘decoding’ the microbiome in support of precision medicine research, and a look at what makes a ‘data-driven’ chemicals and materials industry.
Staying with science for a moment, clinical trials have a been a much-talked-about topic for our clients, and our new client, Phesi, has been producing data showing the current state of play. This has resulted in some insightful pieces on why continued funding of clinical trials throughout the COVID-19 pandemic is so essential, in US publications Applied Clinical Trials and Life Science Leader.
For Blue Yonder, new pan-European research into the shopping habits of 6,000 consumers since the onset of COVID-19 was the main focus. The new data were of considerable interest to journalists, with the team securing great news coverage in key trade titles such as Internet Retailing, Supply Chain Digital, Retail Technology Innovation Hub and Retail Times. Rounding out the week was coverage for the Viasat team in Army Technology, on the company’s recommendations to the MoD around defence procurement processes. And in a swift bit of news-hijacking, the Venafi team placed some comments around the GoDaddy SSH breach on The Register.
There’ll be another Coverage Cup update coming soon, with lots more interesting stories and news to work on in the weeks ahead. In the meantime, we’ll carry on with the cat pictures and revising for our next quiz.
- IDG Connect – Feature looking at the power of APIs
- The Times/Raconteur – Feature on cloud spend with Dynatrace’s comments
- R&D World – Opinion on digitalisation in chemicals and materials
- R&D World – Opinion on precision medicine and the role of the microbiome
- Applied Clinical Trials – Interview with Phesi’s president on clinical trials during COVID-19
- Life Science Leader – Opinion from Phesi on keep clinical trials running
- TechCrunch – Venafi’s acquisition of Jetstack making the news
- MicroScope – Venafi’s acquisition shows deals are still being done
- Internet Retailing – News coverage of Blue Yonder’s pan-European research
- Retail Times – Looking at the longer-term implications of Blue Yonder’s research
- Army Technology – A write-up of Viasat’s recommendations to the MoD
- The Register – News hijacking the GoDaddy SSH breach